Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Assets (2016 - 2026)

Mimedx's Non-Current Assets history spans 17 years, with the latest figure at $68.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 2.78% to $68.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $268.7 million, a 7.44% decrease, with the full-year FY2025 number at $65.2 million, down 9.51% from a year prior.
  • Non-Current Assets hit $68.4 million in Q1 2026 for Mimedx, up from $65.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for MDXG hit a ceiling of $82.8 million in Q1 2024 and a floor of $34.5 million in Q3 2023.
  • Historically, Non-Current Assets has averaged $57.2 million across 5 years, with a median of $65.2 million in 2025.
  • Biggest five-year swings in Non-Current Assets: soared 127.19% in 2024 and later fell 15.12% in 2025.
  • Tracing MDXG's Non-Current Assets over 5 years: stood at $37.2 million in 2022, then soared by 100.86% to $74.8 million in 2023, then fell by 3.69% to $72.0 million in 2024, then fell by 9.51% to $65.2 million in 2025, then rose by 4.86% to $68.4 million in 2026.
  • Business Quant data shows Non-Current Assets for MDXG at $68.4 million in Q1 2026, $65.2 million in Q4 2025, and $64.9 million in Q3 2025.